- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 5/12 - Fused cells, e.g. hybridomas
Patent holdings for IPC class C12N 5/12
Total number of patents in this class: 406
10-year publication summary
|
24
|
28
|
28
|
40
|
22
|
18
|
19
|
3
|
14
|
8
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 4252 |
11 |
| AVEO Pharmaceuticals, Inc. | 84 |
7 |
| Beth Israel Deaconess Medical Center, Inc. | 857 |
7 |
| Dana-Farber Cancer Institute, Inc. | 2562 |
7 |
| Kyowa Kirin Co., Ltd. | 369 |
6 |
| Genentech, Inc. | 3972 |
5 |
| Board of Regents, The University of Texas System | 5782 |
5 |
| Amgen Fremont Inc. | 25 |
5 |
| Daiichi Sankyo Company, Limited | 1862 |
5 |
| Kyoto University | 2800 |
5 |
| Redcoat Solutions, Inc. | 13 |
5 |
| Amgen Inc. | 4073 |
4 |
| ABS Global, Inc. | 133 |
4 |
| Kagoshima University | 308 |
4 |
| NB Health Laboratory Co., Ltd. | 27 |
4 |
| Trianni, Inc. | 49 |
4 |
| Xiamen University | 535 |
4 |
| Pfizer Inc. | 3374 |
3 |
| Gmax Biopharm LLC. | 34 |
3 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3367 |
3 |
| Other owners | 305 |